Skip to main content
CDC Website

TB

Window Treatment After Exposure to Tuberculosis: What Parents Need to Know

The fact sheet includes information on window treatment for children after exposure to TB, such as how to help a child take isoniazid, potential side effects, and when to call a child's doctor. The material also lists symptoms of TB disease in children. 

Nontuberculous Mycobacteria (NTM)

This handout describes nontuberculous mycobacteria (NTM), clinical manifestations, NTM diagnosis, treatment, and action required. The handout also includes 2019 data from the Virginia Department of Health TB Program and links to additional information.

COVID-19 and Tuberculosis

The handout provides information on the similarities and differences between COVID-19 and TB, lists who is at higher risk for TB, and includes additional recommendations. 

Bridges to Build: Improving TB Care for African American Patients

This 90-minute webinar focuses on how anti-black racism impacts African Americans' access to care and the quality of care they receive. The webinar also includes information on specific strategies for clinicians and programs to consider to improve TB care for African American patients.

2017 State and City Tuberculosis Report

This National TB Report publishes key process and outcomes measures for TB control programs in the United States to evaluate progress towards TB elimination.

Latent TB: Updated Treatment Recommendations

In this video CDC's Dr. LoBue discussing the updated recommendations for the 12-dose treatment regimen for latent TB infection.

Implementing The End TB Strategy: The Essentials

2016 is the first year of implementation of the WHO End TB Strategy in the context of the United Nations Sustainable Development Goals Agenda, both of which include the aim of ending the TB epidemic. To support the work ahead, the World Health Organization’s Global TB Programme has developed operational guidance, The Essentials, for effective adaptation and implementation of the new Strategy. The Essentials provides in-depth explanations of the vision, goal, targets, and milestones of the End TB Strategy, as well as key indicators to measure progress.

Lo que usted debe saber sobre su medicamento para la infección latente de tuberculosis (TB) – Isoniazid y Rifapentine

The Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.